Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 3Colonic Neoplasms 3Peritoneal Neoplasms 2Rectal Neoplasms 1Ovarian Neoplasms 1Neoplastic Cells, Circulating 1Melanoma 1Lymphatic Metastasis 1Lung Neoplasms 1Liver Neoplasms 1Genital Neoplasms, Female 1Gastrointestinal Stromal Tumors 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Cholangiocarcinoma 1Carcinoma, Squamous Cell 1Carcinoma, Merkel Cell 1Breast Neoplasms 1Appendiceal Neoplasms 1

Interventions

relacorilant 1nilotinib 1Therapeutic Touch 1Standard of Care 1Radiotherapy 1Practice Guidelines as Topic 1Paclitaxel 1Methods 1Laparoscopy 1Fulvestrant 1Electrocardiography 1Educational Status 1Early Intervention, Educational 1Bevacizumab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genital Neoplasms, Female × Laparoscopy × 90 days × Clear all
NCT05185947 2026-05-29

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
21 enrolled 21 charts
BreastGastrointestinalGynecologic

Appendiceal Neoplasms, Breast Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡